Skip to main content
    B

    Bristol-Myers Squibb Company (BMY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $62.94
    -0.49 (-0.77%)

    Market Cap: $129.66B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Bristol-Myers Squibb Company (BMY) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Bristol-Myers Squibb Company are GSK (GSK), Pfizer (PFE) and Sanofi ADR (SNY). Bristol-Myers Squibb Company trades at 10.1x earnings, against a median of 21.4x for the 9 of these companies with a P/E. By market cap, Bristol-Myers Squibb Company ranks 10th of the 13 companies on this page; AbbVie (ABBV) is the largest at $521.50B.

    Peer Comparison

    BMY's ROIC of 13.9% is above the peer median of 13.5%, and its revenue growth of 6.9% is above the median of 6.8%. Its dividend yield is above the peer median of 2.35%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    AstraZeneca PLC (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Biogen Inc (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Vertex Pharmaceuticals Inc (VRTX)$136.56B30.0x10.5x30.7%14.2%11.8%0.00%
    Peer median$196.00B21.4x5.0x14.3%13.5%6.8%2.35%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Bristol-Myers Squibb Company, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Drug Manufacturers - General; the other one is in Biotechnology.

    CompanyAboutPeers
    GSK plc (GSK)Drug Manufacturers - General
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Pfizer Inc (PFE)Drug Manufacturers - General
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Sanofi ADR (SNY)Drug Manufacturers - General
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Novo Nordisk A/S (NVO)Drug Manufacturers - General
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    Gilead Sciences Inc (GILD)Drug Manufacturers - General
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    AstraZeneca PLC (AZN)Drug Manufacturers - General
    AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory...
    AZN competitors
    Amgen Inc (AMGN)Drug Manufacturers - General
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    Biogen Inc (BIIB)Drug Manufacturers - General
    Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development...
    BIIB competitors
    Merck & Company Inc (MRK)Drug Manufacturers - General
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    Novartis AG ADR (NVS)Drug Manufacturers - General
    Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
    NVS competitors
    AbbVie Inc (ABBV)Drug Manufacturers - General
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Vertex Pharmaceuticals Inc (VRTX)Biotechnology
    Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
    VRTX competitors

    Frequently Asked Questions About BMY

    Who are Bristol-Myers Squibb Company's main competitors?

    The companies most similar to Bristol-Myers Squibb Company include GSK (GSK), Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO) and Gilead Sciences (GILD), listed from the closest match.

    Who is Bristol-Myers Squibb Company's biggest competitor?

    AbbVie (ABBV) is the largest of the similar companies at $521.50B; GSK (GSK) is the closest match by business profile, size, sector and industry.

    How does BMY stock compare with its competitors?

    BMY's P/E is 10.1x against a peer median of 21.4x; its P/S is 2.6x against a peer median of 5.0x; its net margin is 18.5% against a peer median of 14.3%.

    Which of Bristol-Myers Squibb Company's competitors pays a higher dividend?

    Bristol-Myers Squibb Company has a forward dividend yield of 4.00%. Pfizer (PFE), Sanofi ADR (SNY) and Novo Nordisk A/S (NVO) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is Bristol-Myers Squibb Company bigger than its competitors?

    No. Bristol-Myers Squibb Company is 10th by market cap among the 13 companies on this page; the largest is AbbVie (ABBV) at $521.50B.